High glucose concentrations alter the biomineralization process in human osteoblastic cells

Bone

Volumn 50, Issue 1, 2012, Pages 276-288

  Garcia Hernandez A ^a   Arzate, H ^b   Gil Chavarria I ^b   Rojo, R ^a   Moreno Fierros, L ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Biomineralization; High glucose; Osmotic stress osteoclastogenesis; Osteoblast; RANKL and OPG

Indexed keywords

CALCIUM; GLUCOSE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; SIALOPROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR RUNX2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOMINERALIZATION; BONE MINERALIZATION; CALCIFICATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE OVEREXPRESSION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HYPEROSMOTIC STRESS; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOCLASTOGENESIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ALKALINE PHOSPHATASE; BONE REMODELING; CALCIFICATION, PHYSIOLOGIC; CALCIUM; CELLS, CULTURED; CYTOKINES; DIABETES MELLITUS; GLUCOSE; HUMANS; OSTEOBLASTS; OSTEOPROTEGERIN; RANK LIGAND; RNA, MESSENGER; TOLL-LIKE RECEPTORS;

EID: 82055165899     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.10.032     Document Type: Article

References (73)

1. Herder C., Illig T., Rathmann W., Martin S., Haastert B., Muller-Scholze S., et al. Inflammation and type 2 diabetes: results from KORA Augsburg. Gesundheitswesen 2005, 67(Suppl. 1):S115-S121.
2. Devaraj S., Tobias P., Jialal I. Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes. Cytokine 2011 Sep, 55(3):441-445. Epub 2011 Apr 16.
3. Donath M.Y., Shoelson S.E. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011, 11:98-107.
4. Williams R.C. Periodontal disease. N Engl J Med 1990, 322:373-382.
5. Graves D.T. The potential role of chemokines and inflammatory cytokines in periodontal disease progression. Clin Infect Dis 1999, 28:482-490.
6. Nelson R.G., Shlossman M., Budding L.M., Pettitt D.J., Saad M.F., Genco R.J., et al. Periodontal disease and NIDDM in Pima Indians. Diabetes Care 1990, 13:836-840.
7. Taylor G.W., Burt B.A., Becker M.P., Genco R.J., Shlossman M., Knowler W.C., et al. Non-insulin dependent diabetes mellitus and alveolar bone loss progression over 2years. J Periodontol 1998, 69:76-83.
8. Salvi G.E., Collins J.G., Yalda B., Arnold R.R., Lang N.P., Offenbacher S. Monocytic TNF alpha secretion patterns in IDDM patients with periodontal diseases. J Clin Periodontol 1997, 24:8-16.
9. Goova M.T., Li J., Kislinger T., Qu W., Lu Y., Bucciarelli L.G., et al. Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol 2001, 159:513-525.
10. Hotamisligil G.S., Murray D.L., Choy L.N., Spiegelman B.M. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci U S A 1994, 91:4854-4858.
11. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., et al. The hormone resistin links obesity to diabetes. Nature 2001, 409:307-312.
12. Boden G., Chen X., Ruiz J., White J.V., Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 1994, 93:2438-2446.
13. Filippi C.M., Ehrhardt K., Estes E.A., Larsson P., Oldham J.E., von Herrath M.G. TLR2 signaling improves immunoregulation to prevent type 1 diabetes. Eur J Immunol 2011, 41:1399-1409.
14. Sarah S.M., Tamilselvan S., Kamatchiammal S., Suresh R. Expression of Toll-like receptors 2 and 4 in gingivitis and chronic periodontitis. Indian J Dent Res 2006, 17:114-116.
15. Rojo-Botello NR, Garcia-Hernandez AL, Moreno-Fierros L. Expression of toll-like receptors 2, 4 and 9 is increased in gingival tissue from patients with type 2 diabetes and chronic periodontitis. J Periodontal Res in press, doi:. doi:10.1111/j.1600-0765.2011.01405.x.
16. Wong F.S., Wen L. Toll-like receptors and diabetes. Ann N Y Acad Sci 2008, 1150:123-132.
17. Retzlaff C., Yamamoto Y., Hoffman P.S., Friedman H., Klein T.W. Bacterial heat shock proteins directly induce cytokine mRNA and interleukin-1 secretion in macrophage cultures. Infect Immun 1994, 62:5689-5693.
18. Termeer C., Benedix F., Sleeman J., Fieber C., Voith U., Ahrens T., et al. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002, 195:99-111.
19. Tsan M.F., Gao B. Endogenous ligands of Toll-like receptors. J Leukoc Biol 2004, 76:514-519.
20. Hajishengallis G., Tapping R.I., Harokopakis E., Nishiyama S., Ratti P., Schifferle R.E., et al. Differential interactions of fimbriae and lipopolysaccharide from Porphyromonas gingivalis with the Toll-like receptor 2-centred pattern recognition apparatus. Cell Microbiol 2006, 8:1557-1570.
21. Dasu M.R., Devaraj S., Zhao L., Hwang D.H., Jialal I. High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes 2008, 57:3090-3098.
22. Collin H.L., Uusitupa M., Niskanen L., Kontturi-Narhi V., Markkanen H., Koivisto A.M., et al. Periodontal findings in elderly patients with non-insulin dependent diabetes mellitus. J Periodontol 1998, 69:962-966.
23. He H., Liu R., Desta T., Leone C., Gerstenfeld L.C., Graves D.T. Diabetes causes decreased osteoclastogenesis, reduced bone formation, and enhanced apoptosis of osteoblastic cells in bacteria stimulated bone loss. Endocrinology 2004, 145:447-452.
24. Hofbauer L.C., Brueck C.C., Singh S.K., Dobnig H. Osteoporosis in patients with diabetes mellitus. J Bone Miner Res 2007, 22:1317-1328.
25. McCabe L.R. Understanding the pathology and mechanisms of type I diabetic bone loss. J Cell Biochem 2007, 102:1343-1357.
26. Merlotti D., Gennari L., Dotta F., Lauro D., Nuti R. Mechanisms of impaired bone strength in type 1 and 2 diabetes. Nutr Metab Cardiovasc Dis 2010, 20:683-690.
27. Creely S.J., McTernan P.G., Kusminski C.M., Fisher M., Da Silva N.F., Khanolkar M., et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 2007, 292:E740-E747.
28. Song M.J., Kim K.H., Yoon J.M., Kim J.B. Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem Biophys Res Commun 2006, 346:739-745.
29. Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., Flier J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006, 116:3015-3025.
30. El-seweidy M.M., El-Swefy S.E., Ameen R.S., Hashem R.M. Effect of age receptor blocker and/or anti-inflammatory coadministration in relation to glycation, oxidative stress and cytokine production in stz diabetic rats. Pharmacol Res 2002, 45:391-398.
31. Neumann A., Schinzel R., Palm D., Riederer P., Munch G. High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-kappaB activation and cytokine expression. FEBS Lett 1999, 453:283-287.
32. Balint E., Szabo P., Marshall C.F., Sprague S.M. Glucose-induced inhibition of in vitro bone mineralization. Bone 2001, 28:21-28.
33. Botolin S., McCabe L.R. Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways. J Cell Biochem 2006, 99:411-424.
34. Li Y.M., Schilling T., Benisch P., Zeck S., Meissner-Weigl J., Schneider D., et al. Effects of high glucose on mesenchymal stem cell proliferation and differentiation. Biochem Biophys Res Commun 2007, 363:209-215.
35. Kim J.H., Kim Y.Y., Kim S.J. High glucose inhibits gene expression of tyrosyl-tRNA synthetase in osteoblast cells. Methods Find Exp Clin Pharmacol 2009, 31:639-644.
36. Weil B.R., Abarbanell A.M., Herrmann J.L., Wang Y., Meldrum D.R. High glucose concentration in cell culture medium does not acutely affect human mesenchymal stem cell growth factor production or proliferation. Am J Physiol Regul Integr Comp Physiol 2009, 296:R1735-R1743.
37. Zhen D., Chen Y., Tang X. Metformin reverses the deleterious effects of high glucose on osteoblast function. J Diabetes Complications 2010, 24:334-344.
38. Bar-Shavit Z. Taking a toll on the bones: regulation of bone metabolism by innate immune regulators. Autoimmunity 2008, 41:195-203.
39. Ohno T., Okahashi N., Morisaki I., Amano A. Signaling pathways in osteoblast proinflammatory responses to infection by Porphyromonas gingivalis. Oral Microbiol Immunol 2008, 23:96-104.
40. Arzate H., Alvarez-Perez M.A., Aguilar-Mendoza M.E., Alvarez-Fregoso O. Human cementum tumor cells have different features from human osteoblastic cells in vitro. J Periodontal Res 1998, 33:249-258.
41. Kaplow L.S. A histochemical procedure for localizing and evaluating leukocyte alkaline phosphatase activity in smears of blood and marrow. Blood 1955, 10:1023-1029.
42. Gregory C.A., Gunn W.G., Peister A., Prockop D.J. An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem 2004, 329:77-84.
43. Cuisinier F.J., Glaisher R.W., Voegel J.C., Hutchison J.L., Bres E.F., Frank R.M. Compositional variations in apatites with respect to preferential ionic extraction. Ultramicroscopy 1991, 36:297-305.
44. Lowry O.H., Roberts N.R., Leiner K.Y., Wu M.L., Farr A.L. The quantitative histochemistry of brain. I. Chemical methods. J Biol Chem 1954, 207:1-17.
45. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
46. Rio D.C., Ares M., Hannon G.J., Nilsen T.W. Purification of RNA using TRIzol (TRI reagent). Cold Spring Harb Protoc 2010, 2010. [pdb prot5439].
47. Coussens A.K., Hughes I.P., Morris C.P., Powell B.C., Anderson P.J. In vitro differentiation of human calvarial suture derived cells with and without dexamethasone does not induce in vivo-like expression. J Cell Physiol 2009, 218:183-191.
48. Kikuchi T., Matsuguchi T., Tsuboi N., Mitani A., Tanaka S., Matsuoka M., et al. Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors. J Immunol 2001, 166:3574-3579.
49. Gasper N.A., Petty C.C., Schrum L.W., Marriott I., Bost K.L. Bacterium-induced CXCL10 secretion by osteoblasts can be mediated in part through toll-like receptor 4. Infect Immun 2002, 70:4075-4082.
50. Asai Y., Hirokawa Y., Niwa K., Ogawa T. Osteoclast differentiation by human osteoblastic cell line SaOS-2 primed with bacterial lipid A. FEMS Immunol Med Microbiol 2003, 38:71-79.
51. Mo I.F., Yip K.H., Chan W.K., Law H.K., Lau Y.L., Chan G.C. Prolonged exposure to bacterial toxins downregulated expression of toll-like receptors in mesenchymal stromal cell-derived osteoprogenitors. BMC Cell Biol 2008, 9:52.
52. Kadono H., Kido J., Kataoka M., Yamauchi N., Nagata T. Inhibition of osteoblastic cell differentiation by lipopolysaccharide extract from Porphyromonas gingivalis. Infect Immun 1999, 67:2841-2846.
53. Kim H.S., Park J.W., Yeo S.I., Choi B.J., Suh J.Y. Effects of high glucose on cellular activity of periodontal ligament cells in vitro. Diabetes Res Clin Pract 2006, 74:41-47.
54. Evans J.L., Goldfine I.D., Maddux B.A., Grodsky G.M. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?. Diabetes 2003, 52:1-8.
55. Wang L., Nancollas G.H. Pathways to biomineralization and biodemineralization of calcium phosphates: the thermodynamic and kinetic controls. Dalton Trans 2009, 2665-2672.
56. Gopalakrishnan V., Vignesh R.C., Arunakaran J., Aruldhas M.M., Srinivasan N. Effects of glucose and its modulation by insulin and estradiol on BMSC differentiation into osteoblastic lineages. Biochem Cell Biol 2006, 84:93-101.
57. Shoji M., Tanabe N., Mitsui N., Tanaka H., Suzuki N., Takeichi O., et al. Lipopolysaccharide stimulates the production of prostaglandin E2 and the receptor Ep4 in osteoblasts. Life Sci 2006, 78:2012-2018.
58. Johnson K., Moffa A., Chen Y., Pritzker K., Goding J., Terkeltaub R. Matrix vesicle plasma cell membrane glycoprotein-1 regulates mineralization by murine osteoblastic MC3T3 cells. J Bone Miner Res 1999, 14:883-892.
59. Meyer J.L. Can biological calcification occur in the presence of pyrophosphate?. Arch Biochem Biophys 1984, 231:1-8.
60. Poole A.R., Matsui Y., Hinek A., Lee E.R. Cartilage macromolecules and the calcification of cartilage matrix. Anat Rec 1989, 224:167-179.
61. Anderson H.C., Hsu H.H., Morris D.C., Fedde K.N., Whyte M.P. Matrix vesicles in osteomalacic hypophosphatasia bone contain apatite-like mineral crystals. Am J Pathol 1997, 151:1555-1561.
62. Terkeltaub R.A. Inorganic pyrophosphate generation and disposition in pathophysiology. Am J Physiol Cell Physiol 2001, 281:C1-C11.
63. Newsholme P., Haber E.P., Hirabara S.M., Rebelato E.L., Procopio J., Morgan D., et al. Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity. J Physiol 2007, 583:9-24.
64. Delpino M.V., Fossati C.A., Baldi P.C. Proinflammatory response of human osteoblastic cell lines and osteoblast-monocyte interaction upon infection with Brucella spp. Infect Immun 2009, 77:984-995.
65. Zou W., Amcheslavsky A., Bar-Shavit Z. CpG oligodeoxynucleotides modulate the osteoclastogenic activity of osteoblasts via Toll-like receptor 9. J Biol Chem 2003, 278:16732-16740.
66. Ryan K.A., Smith M.F., Sanders M.K., Ernst P.B. Reactive oxygen and nitrogen species differentially regulate Toll-like receptor 4-mediated activation of NF-kappa B and interleukin-8 expression. Infect Immun 2004, 72:2123-2130.
67. Takayanagi H. Mechanistic insight into osteoclast differentiation in osteoimmunology. J Mol Med 2005, 83:170-179.
68. Lee N.K., Choi Y.G., Baik J.Y., Han S.Y., Jeong D.W., Bae Y.S., et al. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 2005, 106:852-859.
69. Forsen L., Meyer H.E., Midthjell K., Edna T.H. Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trondelag Health Survey. Diabetologia 1999, 42:920-925.
70. Nicodemus K.K., Folsom A.R. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care 2001, 24:1192-1197.
71. Campus G., Salem A., Uzzau S., Baldoni E., Tonolo G. Diabetes and periodontal disease: a case-control study. J Periodontol 2005, 76:418-425.
72. Shlossman M., Knowler W.C., Pettitt D.J., Genco R.J. Type 2 diabetes mellitus and periodontal disease. J Am Dent Assoc 1990, 121:532-536.
73. Tsai C., Hayes C., Taylor G.W. Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. Community Dent Oral Epidemiol 2002, 30:182-192.